Pain-Free Results With Sumatriptan Taken at the First Sign of margine Pain: 2 Randomized, Double-Blind, Placebo-Controlled Studies

Winner, Paul; Mannix, Lisa K.; Putnam, Gayla; McNeal, Scott; Kwong, Jackie; O'Quinn, Stephen; Richardson, Mary S.
October 2003
Mayo Clinic Proceedings;Oct2003, Vol. 78 Issue 10, p1214
Academic Journal
Evaluates the efficacy and tolerability of sumatripan compared with placebo for treatment of migraine at the first sign of pain. Results of treatment of migraine at the first sign of pain with sumatripan; Detection of statistical differences between active doses.


Related Articles

  • Drug Combo Better for Migraine Treatment.  // Clinical Cardiology Alert;May2007, Vol. 26 Issue 5, p2 

    The article reports on the results of studies regarding the drug combination in the treatment of acute migraine. They found that the combination of sumatriptan and naproxen is superior to placebo in sustained pain-free response. It was stated that the incidence of adverse effects is similar...

  • Intranasal sumatriptan: in adolescents with migraine. Curran, Monique P.; Evans, Hannah C.; Wagstaff, Antona J. // CNS Drugs;2005, Vol. 19 Issue 4, p335 

    Sumatriptan, a serotonin 5-HT(1B/1D) agonist, constricts cranial blood vessels and inhibits neuroinflammatory processes. A single dose of sumatriptan 10 mg (approved European dosage) was significantly more effective than placebo in achieving headache relief at 1 hour post-dose in a well designed...

  • Spotlight on Eletriptan in Migraine1. McCormack, Paul L.; Keating, Gillian M. // CNS Drugs;2006, Vol. 20 Issue 11, p961 

    Eletriptan (Relpax) is an orally administered, lipophilic, highly selective serotonin 5-HT1B/1D receptor agonist (‘triptan’) that is effective in the acute treatment of moderate to severe migraine attacks in adults. It has a rapid onset of action and demonstrates superiority over...

  • USING ASPIRIN INTRAVENOUSLY. Diener, H.-C. // Journal of Headache & Pain;Apr2006 Supplement, Vol. 7, pS69 

    The article discusses research on the efficacy and safety of intravenous lysine acetyl salicylate (iLAS) in the acute treatment of migraine. It references a study by H. C. Diener published in a previous issue of "Cephalalgia." Findings indicated that both iLAS and sumatriptan were superior to...

  • TREATING MIGRAINE EFFECTIVELY. Diener, H.-C. // Journal of Headache & Pain;Apr2006 Supplement, Vol. 7, pS70 

    The article discusses the treatment of migraine. Acetylsalicylic acid has been used as an analgesic, anti-pyretic and anti-inflammatory drug. The results of an individual patient data meta-analysis of trials with effervescent aspirin in comparison with sumatriptan and placebo in acute migraine...

  • Drug Combo Better for Migraine Treatment. Elliott, William T. // Travel Medicine Advisor;May2007, Vol. 17 Issue 5, p2 

    The article provides information on a study that revealed that naprosyn plus sumatriptan is better than either drug alone for the treatment of acute migraine. The results of the study indicates that sumatriptan plus naproxen was superior to placebo in all measures and was superior to either drug...

  • Pain Free Efficacy of Sumatriptan in the Early Treatment of Migraine. Jelinski, Susan E.; Becker, Werner J.; Christie, Suzanne N.; Ahmad, Faiz F.; Pryse-Phillips, William; Simpson, Scott D. // Canadian Journal of Neurological Sciences;Feb2006, Vol. 33 Issue 1, p73 

    The article presents a study on the use of sumatriptan in the early treatment of migraine. Respondents of the study were treated with placebo, sumatriptan 50 mg or sumatriptan 100 mg in every attack. Results showed that in the intention to treat group, two hour pain free rates were 16 percent,...

  • Non-invasive assessment of selective 5-HT1B/1D-receptor agonist-induced peripheral vascular effects in humans: comparison of different techniques. Vanmolkot, F. H.; de Hoon, J. N.; Barrington, P.; Peck, R. W.; Dallow, N. S.; Williams, P. M.; McColm, J. // European Journal of Clinical Pharmacology;Aug2002, Vol. 58 Issue 5, p303 

    Objective. To compare the sensitivity of three non-invasive techniques for detecting serotonin (5-HT)1B/1D-receptor agonist-induced peripheral vascular effects in humans: the measurement of (1) systolic (SBP) and diastolic (DBP) blood pressures, (2) dorsal hand vein (DHV) diameter and (3)...

  • ALMOTRIPTAN FOR ACUTE MIGRAINE.  // Bandolier;Jan2007, Vol. 14 Issue 1, p4 

    The article describes meta-analysis of trials of almotriptan for acute migraine. Several different doses were used. It presents details of pooled analysis of the four trials of almotriptan compared with placebo in a migraine episode with moderate or severe pain. The study suggests that...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics